Clinical benefits of dexmedetomidine versus propofol in adult intensive care unit patients: A meta-analysis of randomized clinical trials

Journal of Surgical Research

Volumn 185, Issue 2, 2013, Pages 833-843

  Xia, Zhi Qiu ^a   Chen, Shu Qin ^a   Yao, Xi ^a   Xie, Chuan Bo ^a   Wen, Shi Hong ^a   Liu, Ke Xuan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Dexmedetomidine; Intensive care unit; Outcomes; Propofol; Sedation

Indexed keywords

DEXMEDETOMIDINE; PROPOFOL; HYPNOTIC SEDATIVE AGENT;

ARTICLE; ARTIFICIAL VENTILATION; BRADYCARDIA; DELIRIUM; HUMAN; HYPERTENSION; HYPOTENSION; INTENSIVE CARE UNIT; LOADING DRUG DOSE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEDATION; SYSTEMATIC REVIEW; TREATMENT DURATION; ADULT; COMPARATIVE STUDY; CRITICAL ILLNESS; OUTCOMES; REVIEW;

DEXMEDETOMIDINE; INTENSIVE CARE UNIT; OUTCOMES; PROPOFOL; SEDATION;

ADULT; CRITICAL ILLNESS; DEXMEDETOMIDINE; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; PROPOFOL; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84891683426     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.06.062     Document Type: Article

References (68)

1. Mazzeo AJ. Sedation for the mechanically ventilated patient. Crit Care Clin 1995;11:937.
2. Tung A, Rosenthal M. Patients requiring sedation. Crit Care Clin 1995;11:791.
3. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002;30:119.
4. Laine GA, Hossain SM, Solis RT, et al. Polyethylene glycol nephrotoxicity secondary to prolonged high-dose intravenous lorazepam. Ann Pharmacother 1995;29:1110.
5. McCollam JS, O'Neil MG, Norcross ED, et al. Continuous infusions of lorazepam, midazolam, and propofol for sedation of the critically ill surgery trauma patient: a prospective, randomized comparison. Crit Care Med 1999; 27:2454.
6. Trapani G, Altomare C, Liso G, et al. Propofol in anesthesia. Mechanism of action, structure-activity relationships, and drug delivery. Curr Med Chem 2000;7:249.
7. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs 2000;59:263.
8. Venn RM, Karol MD, Grounds RM. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care. Br J Anaesth 2002;88: 669.
9. Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA: J Am Med Assoc 2007;298: 2644.
10. Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA: J Am Med Assoc 2009;301:489.
11. Dasta JF, Kane-Gill SL, Pencina M, et al. A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit. Crit Care Med 2010;38:497.
12. Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www. cochrane-handbook.org.
13. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13.
14. Higgins JP, Deeks JJ. Selecting studies and collecting data. In: Higgins J, Green S (Ed.). Cochrane handbook for systematic reviews of interventions. Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
15. Sterne JAC, Bradburn MJ, Egger M. Meta-analysis in Stata. In: Egger M, Smith GD, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. London: BMJ Publishing Group; 2008. p. 357.
16. Riker RR, Fraser GL. Altering intensive care sedation paradigms to improve patient outcomes. Anesthesiol Clin 2011;29:663.
17. Monk TG, Price CC. Postoperative cognitive disorders. Curr Opin Crit Care 2011;17:376.
18. Bracco D, Donatelli F. Volatile agents for ICU sedation? Intensive Care Med 2011;37:895.
19. Dexmedetomidine (Precedex) for ICU sedation. Med Lett Drugs Ther 2011;53:41.
20. Nseir S, Makris D, Mathieu D, et al. Intensive Care Unit-acquired infection as a side effect of sedation. Crit Care 2010; 14:R30.
21. Arnold HM, Hollands JM, Skrupky LP, et al. Optimizing sustained use of sedation in mechanically ventilated patients: focus on safety. Curr Drug Saf 2010;5:6.
22. Riker RR, Fraser GL. Altering intensive care sedation paradigms to improve patient outcomes. Crit Care Clin 2009; 25:527.
23. Arcangeli A, D'Alo C, Gaspari R. Dexmedetomidine use in general anaesthesia. Curr Drug Targets 2009;10:687.
24. Keegan MT. Sedation in the neurologic intensive care unit. Curr Treat Options Neurol 2008;10:111.
25. Devlin JW. The pharmacology of oversedation in mechanically ventilated adults. Curr Opin Crit Care 2008; 14:403.
26. Carollo DS, Nossaman BD, Ramadhyani U. Dexmedetomidine: a review of clinical applications. Curr Opin Anaesthesiol 2008;21:457.
27. Szumita PM, Baroletti SA, Anger KE, et al. Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine. Am J Health Syst Pharm 2007;64:37.
28. Zapantis A, Leung S. Tolerance and withdrawal issues with sedation. Crit Care Nurs Clin North Am 2005;17:211.
29. Tung A. New anesthesia techniques. Thorac Surg Clin 2005; 15:27.
30. Riker RR, Fraser GL. Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit. Pharmacotherapy 2005; 25:8S.
31. Taiji K. [Dexmedetomidine hydrochloride (Precedex), a new sedative in intensive care, its pharmacological characteristics and clinical study result]. Nihon Yakurigaku Zasshi 2004;124:171.
32. Nasraway SA Jr. Use of sedative medications in the intensive care unit. Semin Respir Crit Care Med 2001;22:165.
33. Coursin DB, Maccioli GA. Dexmedetomidine. Curr Opin Crit Care 2001;7:221.
34. Angelini G, Ketzler JT, Coursin DB. Use of propofol and other nonbenzodiazepine sedatives in the intensive care unit. Crit Care Clin 2001;17:863.
35. Ohashi Y, Ohta N, Hirao O, et al. Analgesic effect of dexmedetomidine in a patient with herpetic stomatitis after living-donor lung transplantation. J Anesth 2008;22:297.
36. Matsumoto K, Yanagita W, Miki S. [Ultra fast-track anesthesia with operating room extubation in a patient undergoing OPCABG by combination of propofol-remifentanil-dexmedetomidine]. Masui 2008;57:206.
37. Santos MC, Vinagre RC. [Dexmedetomidine for neurocognitive testing in awake craniotomy: case report]. Rev Bras Anestesiol 2006;56:402.
38. Braz LG, Camacho Navarro LH, Braz JR, et al. [Clonidine as adjuvant therapy for alcohol withdrawal syndrome in intensive care unit: case report]. Rev Bras Anestesiol 2003; 53:802.
39. Reichert MG, Jones WA, Royster RL, et al. Effect of a dexmedetomidine substitution during a nationwide propofol shortage in patients undergoing coronary artery bypass graft surgery. Pharmacotherapy 2011;31:673.
40. Devabhakthuni S, Pajoumand M, Williams C, et al. Evaluation of dexmedetomidine: safety and clinical outcomes in critically ill trauma patients. J Trauma 2011;71:1164.
41. Reade MC, O'Sullivan K, Bates S, et al. Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial. Crit Care 2009;13:R75.
42. Martin E, Ramsay G, Mantz J, et al. The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intensive Care Med 2003; 18:29.
43. Venn M, Newman J, Grounds M. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med 2003;29:201.
44. Mirski MA, Lewin JJ 3rd, Ledroux S, et al. Cognitive improvement during continuous sedation in critically ill, awake and responsive patients: the Acute Neurological ICU Sedation Trial (ANIST). Intensive Care Med 2010;36:1505.
45. Memis D, Dokmeci D, Karamanlioglu B, et al. A comparison of the effect on gastric emptying of propofol or dexmedetomidine in critically ill patients: preliminary study. Eur J Anaesthesiol 2006;23:700.
46. Maldonado JR, Wysong A, van der Starre PJ, et al. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics 2009;50:206.
47. Corbett SM, Rebuck JA, Greene CM, et al. Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Crit Care Med 2005; 33:940.
48. Jakob SM, Ruokonen E, Grounds RM, et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA: J Am Med Assoc 2012;307:1151.
49. Elbaradie S, El Mahalawy FH, Solyman AH. Dexmedetomidine vs. propofol for short-term sedation of postoperative mechanically ventilated patients. J Egypt Natl Canc Inst 2004;16:153.
50. Venn RM, Bryant A, Hall GM, et al. Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth 2001;86:650.
51. Memis D, Kargi M, Sut N. Effects of propofol and dexmedetomidine on indocyanine green elimination assessed with LIMON to patients with early septic shock: a pilot study. J Crit Care 2009;24:603.
52. Herr DL, Sum-Ping ST, England M. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth 2003;17:576.
53. Kaneko T. [Postoperative management of carotid endarterectomy with dexmedetomidineea comparison with propofol]. Masui 2008;57:696.
54. Tasdogan M, Memis D, Sut N, et al. Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis. J Clin Anesth 2009;21:394.
55. Anger KE, Szumita PM, Baroletti SA, et al. Evaluation of dexmedetomidine versus propofol-based sedation therapy in mechanically ventilated cardiac surgery patients at a tertiary academic medical center. Crit Pathw Cardiol 2010;9:221.
56. Aoki M, Nishimura Y, Baba H, et al. [Effects of dexmedetomidine hydrochloride on postoperative sedation in cardiovascular surgery]. Kyobu Geka 2006;59:1181.
57. Ruokonen E, Parviainen I, Jakob SM, et al. Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation. Intensive Care Med 2009; 35:282.
58. Lin YY, He B, Chen J, et al. Can dexmedetomidine be a safe and efficacious sedative agent in post-cardiac surgery patients? a meta-analysis. Crit Care 2012;16:R169.
59. Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA: J Am Med Assoc 2004;291: 1753.
60. Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA: I Am Med Assoc 2001;286:2703.
61. Milbrandt EB, Deppen S, Harrison PL, et al. Costs associated with delirium in mechanically ventilated patients. Crit Care Med 2004;32:955.
62. Kahraman S, Zup SL, McCarthy MM, et al. GABAergic mechanism of propofol toxicity in immature neurons. J Neurosurg Anesthesiology 2008;20:233.
63. Bloor BC, Ward DS, Belleville JP, et al. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 1992;77:1134.
64. Ebert TJ, Hall JE, Barney JA, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93:382.
65. Dasta JF, Kane-Gill SL, Durtschi AJ. Comparing dexmedetomidine prescribing patterns and safety in the naturalistic setting versus published data. Ann Pharmacother 2004;38:1130.
66. Shehabi Y, Ruettimann U, Adamson H, et al. Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Med 2004;30:2188.
67. Gerlach AT, Dasta JF. Dexmedetomidine: an updated review. Ann Pharmacother 2007;41:245.
68. Tan JA, Ho KM. Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis. Intensive Care Med 2010;36:926.